latest newsRead more...
15
Oct 2018The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries
The Menarini Group an Italian biopharmaceutical company present in countries worldwide and Melinta Therapeutics a US company dedicated to the discovery development and commercialization of novel antibiotics to treat serious bacterial infections have announced an agreement under which Menarini will acquire the exclusive rights to…
15
Oct 2018Telix and ANMI Expand PSMA Imaging Partnership
Telix Pharmaceuticals Limited a clinicalstage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularlytargeted radiation MTR today announced that it has expanded its partnership with Advanced Nuclear Medicine Ingredients SA ANMI for the GaHBEDCCPSMA GaPSMA cold kit…
12
Oct 2018Bristol-Myers Squibb and Compugen Announce Clinical Collaboration to Evaluate Therapeutic Regimen
BristolMyers Squibb Company and Compugen today announced the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Compugens COM an investigational antiPVRIG antibody in combination with BristolMyers Squibbs programmed death PD immune checkpoint inhibitor Opdivo nivolumab in patients with…
12
Oct 2018Mundipharma Strengthens Position as a Leader in Biosimilars with Acquisition of Development Company Cinfa Biotech
The Mundipharma global network of independent associated companies has today added development capabilities to its biosimilars platform with the purchase of biosimilars development company Cinfa Biotech The announcement sees the Mundipharma network including NAPP Pharmaceuticals in the UK gain immediate access to Pelmeg B a…
11
Oct 2018ROSLINCT and REPROCELL Awarded £1.2 Million from Innovate UK for Clinical-Grade Stem Cell Production
ROSLINCT a leading cell and gene therapy contract manufacturing organisation today announced it is to receive a million investment to collaborate with REPROCELL Europe Ltd REPROCELL a UKbased stem cell company on a project which will develop a faster more costeffective method of producing clinicalgrade…
press releasesRead more...
15
Oct 2018MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD
MaaT Pharma announced today the dosing of the first patient in a Phase clinical trial of its lead microbiome restoration candidate MaaT in patients with steroidresistant acute GraftversusHostDisease SRaGvHD the…
12
Oct 2018Synspira Receives U.S. FDA Orphan Designation for PAAG15A for the Treatment of Cystic Fibrosis
Synspira a privately held company developing a new class of inhaled glycopolymerbased therapeutics for the treatment of pulmonary disease today announced that it has been granted Orphan Designation by the…
12
Oct 2018ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease
ProMIS Neurosciences Inc a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases today announced the identification of…
11
Oct 2018Antibe Therapeutics Receives Approval to Initiate Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346
Antibe Therapeutics Inc a leader in developing safer therapeutics for pain and inflammation is pleased to announce that it has received approval from Health Canada to initiate the first part…
11
Oct 2018AUM LifeTech, CHOP and Penn Partnering to Advance Cancer Immunotherapy Against Lung Cancer Using Foxp3 Gene Silencing FANA ASO Therapy
AUM LifeTech Inc a Philadelphiabased biotech company has partnered with the Childrens Hospital of Philadelphia CHOP and the Perelman School of Medicine at the University of Pennsylvania to employ nextgeneration…
EventsRead more...
15-17
Oct 2018IFAT India 2018
Messe Muenchen India Pvt. Ltd.
Bombay Exhibition Centre
15-17
Oct 20187th European TMF Summit
ExL Events, Inc.
Hilton London Bankside
16-18
Oct 2018TIACA’s International Air Cargo Forum and Exhibition 2018
TIACA
Metro Toronto Convention Centre
16-17
Oct 201815th Annual Patient Summit Europe
Eyeforpharma
Novotel London West Hotel
TOP ARTICLES
-
1
Smart Nano-Enabled Drug Career in Combating Tumor Development and Progress
Introduction The worldwide report of mortality due to lethal disease cancer is common and progressive nowadays Although nanomedicine advances in tumor biolog..
-
2
Are you Ready for EU FMD?
With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
-
3
Life-style, Environment, and Lack of Prediabetes Diagnosis Fueling Diabetic Epidemic
Introduction For the past ten years ample evidence exists to suggest that what we eat and how we live determines how our body and genes behave A rapid rise i..
-
4
Cancer Stem Cell (CSC) Inhibitors
Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..
-
5
Enhancement of the Aqueous Solubility and Permeability of Poorly Water- Soluble Drugs
Introduction Combinatorial chemistry High Throughput Screening technique HTS and other computeraided methods have proved their usefulness for drug design and..
-
6
Blood-Brain Barrier and CNS Drug Delivery
Introduction The idea of Blood Brain Barrier BBB dates back to more than years ago when Paul Erlich observed that by intravenous injection of certain dyes all..
Knowledge Bank
-
Interviews
Merck
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..
-
Articles
Machine Learning: The Next Generation Manufacturing For Pharmaceutical Industry
The pharmaceutical industry will be worth US trillion by in terms of total prescription drug sales The market evaluation of machine learning industry will be worth US billion by as quoted in Machine Learning Report published by Vertical Now when you integrate machine learning into the pharmaceutical industry you can estimate the staggering growth…
-
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to investigate the efficacy and safety of afatinib an irreversible ErbB family inhibitor alone and in combination with vinorelbine…
-
Case Studies
Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime WGS with routine MTBC diagnostic workflows Methods We compared…
-
Techno Trends
Alnylam’s ONPATTRO to Treat Patients with Hereditary ATTR Amyloidosis in Adults
Alnylams ONPATTRO patisiran lipid complex injection is a firstofitskind RNA interference RNAi therapeutic used to treat the polyneuropathy of hereditary transthyretinmediated hATTR Amyloidosis in adults RNAi is a completely new approach to the treatment of these diseases targeting the faulty protein that is causing the disease rather than treating the symptoms RNAi therapeutic is an entirely new class of medicines…
-
White Papers
Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward ascending regions such as India and China to…
-
Industry Reports
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
Sanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration pain and cancer as well as diagnostic products based on contrast media The companys product portfolio includes radiological products including an array of xray imaging…
Advisory Board
Editorial Section
-
Strategy
Statin Drug Interactions and Related Adverse Reactions
Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting…
-
Research development
Stem Cell and Gene Delivery
These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem…
-
Clinical Trials
Managing Clinical Trial Agreements
Clinical Trial Agreements set out how a clinical trial will be run at the site and are an essential GCP document There are a number of key factors that determine whether a Clinical Trial Agreement is successful in achieving that…
-
Manufacturing
Drug Concentration Assurance of Continuous Tablet Manufacturing
In the pharmaceutical industry Real Time Release RTR can be facilitated by the development of a highly efficient control system The drug concentration in final tablet is one of the most critical quality attributes that…
-
Information Technology
R&D DATA HUB
Faster decision making and better trial oversight at all levels requires truly next generation data integration and analytics Source and format agnostic data aggregation aided by modern data lake architecture and advanced analytics deliver interactive…
